Distinct strains of Leishmania major induce different cytokine mRNA expression in draining lymph node of BALB/c mice

Parasite Immunology

Volumn 35, Issue 1, 2013, Pages 42-50

  Asadpour, A ^a   Riazi Rad, F ^a   Khaze, V ^a   Ajdary, S ^a   Alimohammadian, Mohammad Hossein ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Cytokine mRNA; Leishmania major; Parasite burden; Real time PCR; SSCP

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; FEMALE; GENE EXPRESSION; IMMUNOGENICITY; INOCULATION; LEISHMANIA MAJOR; LYMPH NODE; MOUSE; NONHUMAN; PARASITE LOAD; PARASITE VIRULENCE; POPLITEAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TH1 CELL;

ANIMALS; ANTIBODY FORMATION; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE; MICE, INBRED BALB C; PARASITE LOAD; VIRULENCE;

LEISHMANIA MAJOR; MUS;

EID: 84871163443     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12018     Document Type: Article

References (31)

1. Seimenis A, Morelli D & Mantovani A. Zoonoses in the Mediterranean region. Ann Ist Supper Sanit 2006; 42: 437-445.
2. Gramiccia M & Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. Int J parasitol 2005; 35: 1169-1180.
3. Mauel J & Behin R. Immunology of human leishmaniasis. In Peters W & Killick-Kendrick R (eds): The Leishmaniases in Biology and Medicine. London, Academic Press, 1987; 731-791.
4. Belkaid Y, Piccirilo CA, Mendez S, Shevach EM & Sacks DL. CD4 + CD25 + regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502-507.
5. Rogers KA, Dekrey GK, Mbow ML, Gillespie RD, Brodskyn CI & Titus RG. Type 1 and Type 2 responses to Leishmania major. FEMS Microbiol Lett 2002; 209: 1-7.
6. Muller I, Fruth U & Louis JA. Immunobiology of experimental leishmaniasis. Med Microbiol Immunol 1992; 181: 1-12.
7. Launois P, Tacchini-Cottier F, Parra-Lopez C & Louis JA. Cytokines in parasitic diseases: the example of cutaneous leishmaniasis. Int Rev Immumol 1998; 17: 157-180.
8. Sacks D & Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002; 9: 845-858.
9. Scharton-Kersten T & Scott P. The role of the innate immune response in Th1 cell development following Leishmania major infection. J Leukocyte Biol 1995; 57: 515-522.
10. Reiner SL & Locksly RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13: 151-177.
11. Kebaier C, Louzir H, Chenik M, Ben Saleh A & Dellagi K. Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response. Infect Immun 2001; 69: 4906-4915.
12. Indiani-Oliveira C, Teixeira MJ, Teixeira CR, et al. Leishmania braziliensis isolates differing at the genome level display distinction features in BALB/c mice. Microbes Infect 2004; 6: 977-984.
13. Almeida RP, Barral-Netto M, De Jesus AM, De Freitas LA, Carvalho EM & Barral A. Biological behaviour of Leishmania amazonensis isolated from human with cutaneous, mucosal, or visceral leishmaniasis in BALB/c mice. Am J Trop Med Hyg 1996; 54: 178-184.
14. Alimohammadian MH, Darabi H, Ajdary S, Khaze V & Torkabadi E. Genotypically distinct strains of Leishmania major display diverse clinical and immunological patterns in BALB/c mice. Infect Genet Evol 2010; 10: 969-975.
15. Schonian G, Schnur L, el Fari M, et al. Genetic heterogeneity in the species Leishmania tropica revealed by different PCR-based methods. Trans R Soc Trop, Med Hyg 2001; 95: 217-224.
16. El Tai NO, El Fari M, Mauricio I, et al. Genetic heterogeneity in the species Leishmania tropica revealed by different PCR-based methods. Trans R Soc Trop Med Hyg 2001; 95: 217-224.
17. Titus RG, Marchand M, Boom T & Louis JA. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 1985; 7: 545-555.
18. Kropf P, Muller I, Brunson K & Etges R. The leishmaniasis model. In Kaufmann SHE & Kabelitz D. (eds): Immunology of Infection, 2nd edn. London, Academic Press, 1998; 419-452.
19. Taswell C.Limiting dilution assays for the separation, characterization, and quantitation of biologically active particles and their clonal progeny. In Pretlow TG & Pretlow TP.(eds): Cell separation: Methods and selected applications. Vol. 4, London, Academic Press, 1987; 109-145.
20. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R & Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 2003; 14: 33-43.
21. Bullen DV, Baldwin TM, Curtis JM, Alexander WS & Handman E. Persistence of lesions in suppressor of cytokine signaling-1-deficient mice infected with Leishmania major. J Immunol 2003; 170: 4267-4272.
22. T difference" formula. J Mol Med 2006; 84: 901-910.
23. T method. Methods 2001; 25: 402-408.
24. Gumy A, Aseffa A, Rachinel N, et al. Lack-reactive CD4 + T cells require autocrine IL-2 to mediate susceptibility to Leishmania major. Eur J Immunol 2006; 36: 1465-1473.
25. Reiner SL, Zheng S, Wang ZE, Stowring L & Locksley RM. Leishmania promastigotes evade interleukin 12 (IL-12) inductions by macrophages and stimulate a broad range of cytokines from CD4 + T cells during initiation of infection. J Exp Med 1994; 179: 447-456.
26. Sypeck JP, Chung CL, Mayor SHE, et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 1993; 177: 1797-1802.
27. Louis JA, Gumy A, Voigt H, Launois P & Rocken M. The use of the murine model of infection with Leishmania major to reveal the antagonistic effects that IL-4 can exert on T helper cell development and demonstrate that these opposite effects depend upon the nature of the cells targeted for IL-4 signaling. Pathol Biol (Paris) 2003; 51: 71-73.
28. Launois P, Maillard I, Pingel S, et al. IL-4 rapidly produced by Vβ4 Vα8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 1997; 6: 541-549.
29. Launois P, Ohteki T, Swihart K, MacDonald HR & Louis J.A. In susceptible mice Leishmania major induce very rapid interleukin-4 production by CD4 + T cells which are NK1.1. Eur J Immunol 1995; 25: 3298-3307.
30. Ronet C, Torre YH, Revaz-Breton M, et al. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J Immunol 2010; 184: 886-894.
31. Noben-Trauth N, Lira R, Nagase H, Paul WE & Sacks DL. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J Immunol 2003; 170: 5152-5158.